XML 25 R14.htm IDEA: XBRL DOCUMENT
v3.24.3

FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS | 9 Months Ended
--- | ---
Sep. 30, 2024
Fair Value Disclosures [Abstract] |
FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS | FINANCIAL INSTRUMENTS AND FAIR VALUE MEASUREMENTS Financial assets and liabilities measured at fair value on a recurring basis are summarized below:
| September 30, 2024 |  | December 31, 2023
Dollars in millions | Level 1 |  | Level 2 |  | Level 3 |  | Level 1 |  | Level 2 |  | Level 3
Cash and cash equivalents |  |  |  |  |  |  |  |  |  |  |
Money market and other securities | $ | — |  |  | $ | 5,589 |  |  | $ | — |  |  | $ | — |  |  | $ | 8,489 |  |  | $ | — |
Marketable debt securities |  |  |  |  |  |  |  |  |  |  |
Certificates of deposit | — |  |  | 18 |  |  | — |  |  | — |  |  | 609 |  |  | — |
Commercial paper | — |  |  | — |  |  | — |  |  | — |  |  | 92 |  |  | — |
Corporate debt securities | — |  |  | 483 |  |  | — |  |  | — |  |  | 460 |  |  | — |
U.S. Treasury securities | — |  |  | 27 |  |  | — |  |  | — |  |  | 19 |  |  | — |
Derivative assets | — |  |  | 271 |  |  | — |  |  | — |  |  | 219 |  |  | — |
Equity investments | 600 |  |  | 88 |  |  | — |  |  | 318 |  |  | 141 |  |  | — |
Derivative liabilities | — |  |  | 173 |  |  | — |  |  | — |  |  | 160 |  |  | — |
Contingent consideration liability |  |  |  |  |  |  |  |  |  |  |
Contingent value rights(a) | 2 |  |  | — |  |  | 248 |  |  | 4 |  |  | — |  |  | — |
Other acquisition related contingent consideration | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 8 |
(a) Includes the fair value of contingent value rights associated with the Mirati acquisition as further described in "—Note 4. Acquisitions, Divestitures, Licensing and Other Arrangements." The fair value of the contingent value rights was estimated using a probability-weighted expected return method. As further described in "Item 8. Financial Statements and Supplementary Data—Note 9. Financial Instruments and Fair Value Measurements" in the Company's 2023 Form 10-K, the Company's fair value estimates use inputs that are either (1) quoted prices for identical assets or liabilities in active markets (Level 1 inputs); (2) observable prices for similar assets or liabilities in active markets or for identical or similar assets or liabilities in markets that are not active (Level 2 inputs); or (3) unobservable inputs (Level 3 inputs). The fair value of Level 2 equity investments is adjusted for characteristics specific to the security and is not adjusted for contractual sale restrictions. Equity investments subject to contractual sale restrictions were not material as of September 30, 2024 and December 31, 2023. Marketable Debt Securities The amortized cost for marketable debt securities approximates its fair value and these securities mature within five years as of September 30, 2024, and four years as of December 31, 2023. Equity Investments The following summarizes the carrying amount of equity investments:
Dollars in millions | September 30, 2024 |  | December 31, 2023
Equity investments with RDFV | $ | 688 |  |  | $ | 459 |
Equity investments without RDFV | 841 |  |  | 698 |
Limited partnerships and other equity method investments | 578 |  |  | 542 |
Total equity investments | $ | 2,107 |  |  | $ | 1,699 |
The following summarizes the activity related to equity investments. Changes in fair value of equity investments are included in Other (income)/expense, net.
| Three Months Ended September 30, |  | Nine Months Ended September 30,
Dollars in millions | 2024 |  | 2023 |  | 2024 |  | 2023
Equity investments with RDFV |  |  |  |  |  |  |
Net (gain)/loss recognized | $ | (33) |  |  | $ | 15 |  |  | $ | (155) |  |  | $ | 203 |
Less: net (gain)/loss recognized on investments sold | (3) |  |  | (86) |  |  | (2) |  |  | 2 |
Net unrealized (gain)/loss recognized on investments still held | (30) |  |  | 101 |  |  | (153) |  |  | 201 |
Equity investments without RDFV |  |  |  |  |  |  |
Upward adjustments | (15) |  |  | (3) |  |  | (36) |  |  | (9) |
Net realized (gain)/loss recognized on investments sold | — |  |  | — |  |  | (36) |  |  | — |
Impairments and downward adjustments | 13 |  |  | 6 |  |  | 42 |  |  | 6 |
Limited partnerships and other equity method investments |  |  |  |  |  |  |
Equity in net loss/(income) of affiliates | 23 |  |  | (18) |  |  | (36) |  |  | 13 |
Total equity investment (gains)/losses | $ | (12) |  |  | $ | — |  |  | $ | (221) |  |  | $ | 213 |
Cumulative upwards adjustments and cumulative impairments and downward adjustments based on observable price changes in equity investments without RDFV still held as of September 30, 2024 were $220 million and $98 million, respectively. Qualifying Hedges and Non-Qualifying Derivatives Cash Flow Hedges BMS enters into foreign currency forward and purchased local currency put option contracts (foreign exchange contracts) to hedge certain forecasted intercompany inventory sales, third party sales and certain other foreign currency transactions. The objective of these foreign exchange contracts is to reduce variability caused by changes in foreign exchange rates that would affect the U.S. dollar value of future cash flows derived from foreign currency denominated sales, primarily the euro and Japanese yen. The fair values of these derivative contracts are recorded as either assets (gain positions) or liabilities (loss positions) in the consolidated balance sheets. Changes in fair value for these foreign exchange contracts, which are designated as cash flow hedges, are temporarily recorded in Accumulated other comprehensive loss ("AOCL") and reclassified to net earnings when the hedged item affects earnings (typically within the next 24 months). As of September 30, 2024, assuming market rates remain constant through contract maturities, BMS expects to reclassify pretax losses of $23 million into Cost of products sold for our foreign exchange contracts out of AOCL during the next 12 months. The notional amount of outstanding foreign currency exchange contracts was primarily $4.1 billion for the euro contracts and $1.2 billion for Japanese yen contracts as of September 30, 2024. BMS also enters into cross-currency swap contracts to hedge exposure to foreign currency exchange rate risk associated with its long-term debt denominated in euros. These contracts convert interest payments and principal repayment of the long-term debt to U.S. dollars from euros and are designated as cash flow hedges. The unrealized gains and losses on these contracts are reported in AOCL and reclassified to Other (income)/expense, net, in the same periods during which the hedged debt affects earnings. The notional amount of cross-currency swap contracts associated with long-term debt denominated in euros was $1.2 billion as of September 30, 2024. In January 2024, BMS entered into forward interest rate contracts of a total notional value of $5.0 billion to hedge future interest rate risk associated with the unsecured senior notes issued in February 2024. The forward interest rate contracts were designated as cash flow hedges and terminated upon the issuance of the unsecured senior notes. The $131 million gain on the transaction was included in Other Comprehensive (Loss)/Income and is amortized as a reduction to interest expense over the term of the related debt. Amounts expected to be recognized during the subsequent 12 months on forward interest rate contracts are not material. Cash flow hedge accounting is discontinued when the forecasted transaction is no longer probable of occurring within 60 days after the originally forecasted date or when the hedge is no longer effective. Assessments to determine whether derivatives designated as qualifying hedges are highly effective in offsetting changes in the cash flows of hedged items are performed at inception and on a quarterly basis. The earnings impact related to discontinued cash flow hedges and hedge ineffectiveness was not material during all periods presented. Foreign currency exchange contracts not designated as a cash flow hedge offset exposures in certain foreign currency denominated assets, liabilities and earnings. Changes in the fair value of these derivatives are recognized in earnings as they occur. Net Investment Hedges Cross-currency swap contracts and foreign currency forward contracts of $1.5 billion as of September 30, 2024 are designated to hedge currency exposure of BMS's net investment in its foreign subsidiaries. Contract fair value changes are recorded in the foreign currency translation component of AOCL with a related offset in derivative asset or liability in the consolidated balance sheets. The notional amount of outstanding cross-currency swap and foreign currency forward contracts was primarily attributed to the Japanese yen of $713 million and euro of $721 million as of September 30, 2024. In 2023, the Company de-designated its remaining net investment hedge in debt denominated in euros of €375 million. The related net investment hedge was entered into to hedge euro currency exposures of the net investment in certain foreign affiliates and was recognized in Long-term debt. The effective portion of foreign exchange gain or loss on the remeasurement of debt denominated in euros was included in the foreign currency translation component of AOCL with the related offset in Long-term debt. During the three and nine months ended September 30, 2024, the amortization of gains related to the portion of our net investment hedges that was excluded from the assessment of effectiveness was not material. Fair Value Hedges Fixed to floating interest rate swap contracts are designated as fair value hedges and used as an interest rate risk management strategy to create an appropriate balance of fixed and floating rate debt. The contracts and underlying debt for the hedged benchmark risk are recorded at fair value. Gains or losses resulting from changes in fair value of the underlying debt attributable to the hedged benchmark interest rate risk are recorded in interest expense with an associated offset to the carrying value of debt. Since the specific terms and notional amount of the swap are intended to align with the debt being hedged, all changes in fair value of the swap are recorded in interest expense with an associated offset to the derivative asset or liability in the consolidated balance sheets. As a result, there was no net impact in earnings. If the underlying swap is terminated prior to maturity, then the fair value adjustment to the underlying debt is amortized as a reduction to interest expense over the remaining term of the debt. Derivative cash flows, with the exception of net investment hedges, are principally classified in the operating section of the consolidated statements of cash flows, consistent with the underlying hedged item. Cash flows related to net investment hedges are classified in investing activities. The following table summarizes the fair value and the notional values of outstanding derivatives:
| September 30, 2024 |  | December 31, 2023
| Asset(a) |  | Liability(b) |  | Asset(a) |  | Liability(b)
Dollars in millions | Notional |  | Fair Value |  | Notional |  | Fair Value |  | Notional |  | Fair Value |  | Notional |  | Fair Value
Designated as cash flow hedges |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency exchange contracts | $ | 5,246 |  |  | $ | 110 |  |  | $ | 1,193 |  |  | $ | (41) |  |  | $ | 4,772 |  |  | $ | 130 |  |  | $ | 1,971 |  |  | $ | (66) |
Cross-currency swap contracts | 1,210 |  |  | 53 |  |  | — |  |  | — |  |  | 1,210 |  |  | 50 |  |  | — |  |  | — |
Designated as net investment hedges |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency exchange contracts | 378 |  |  | 5 |  |  | 448 |  |  | (7) |  |  | — |  |  | — |  |  | 215 |  |  | (8) |
Cross-currency swap contracts | 308 |  |  | 3 |  |  | 400 |  |  | (29) |  |  | — |  |  | — |  |  | 747 |  |  | (43) |
Designated as fair value hedges |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Interest rate swap contracts | 3,500 |  |  | 19 |  |  | 255 |  |  | (8) |  |  | 2,500 |  |  | 3 |  |  | 1,755 |  |  | (14) |
Not designated as hedges |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Foreign currency exchange contracts | 4,468 |  |  | 76 |  |  | 5,180 |  |  | (88) |  |  | 906 |  |  | 20 |  |  | 1,250 |  |  | (29) |
Total return swap contracts (c) | $ | 455 |  |  | $ | 5 |  |  | $ | — |  |  | $ | — |  |  | $ | 401 |  |  | $ | 16 |  |  | $ | — |  |  | $ | — |
(a) Included in Other current assets and Other non-current assets. (b) Included in Other current liabilities and Other non-current liabilities. (c) Total return swap contracts hedge changes in fair value of certain deferred compensation liabilities. The following table summarizes the financial statement classification and amount of (gain)/loss recognized on hedges:
|  | Three Months Ended September 30, 2024 |  | Nine Months Ended September 30, 2024
Dollars in millions |  | Cost of products sold |  | Other (income)/expense, net |  | Cost of products sold |  | Other (income)/expense, net
Foreign currency exchange contracts |  | $ | (3) |  |  | $ | 7 |  |  | $ | (77) |  |  | $ | (46) |
Cross-currency swap contracts |  | — |  |  | (55) |  |  | — |  |  | (19) |
Interest rate swap contracts |  | — |  |  | 4 |  |  | — |  |  | 11 |
Forward interest rate contracts |  | — |  |  | (1) |  |  | — |  |  | (3) |
| Three Months Ended September 30, 2023 |  | Nine Months Ended September 30, 2023
Dollars in millions | Cost of products sold |  | Other (income)/expense, net |  | Cost of products sold |  | Other (income)/expense, net
Foreign currency exchange contracts | $ | (51) |  |  | $ | (40) |  |  | $ | (261) |  |  | $ | (100) |
Cross-currency swap contracts | — |  |  | 26 |  |  | — |  |  | (2) |
Interest rate swap contracts | — |  |  | — |  |  | — |  |  | (7) |
The following table summarizes the effect of derivative and non-derivative instruments designated as hedges in Other comprehensive income:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
Dollars in millions | 2024 |  | 2023 |  | 2024 |  | 2023
Derivatives designated as cash flow hedges |  |  |  |  |  |  |
Foreign exchange contracts gain/(loss): |  |  |  |  |  |  |
Recognized in Other comprehensive (loss)/income | $ | (195) |  |  | $ | 173 |  |  | $ | 46 |  |  | $ | 226 |
Reclassified to Cost of products sold | (3) |  |  | (51) |  |  | (77) |  |  | (261) |
Cross-currency swap contracts gain/(loss): |  |  |  |  |  |  |
Recognized in Other comprehensive (loss)/income | 36 |  |  | (23) |  |  | 2 |  |  | 5 |
Reclassified to Other (income)/expense, net | (53) |  |  | 35 |  |  | (12) |  |  | 26 |
Forward interest rate contract gain/(loss): |  |  |  |  |  |  |
Recognized in Other comprehensive (loss)/income | — |  |  | — |  |  | 131 |  |  | — |
Reclassified to Other (income)/expense, net | (1) |  |  | — |  |  | (3) |  |  | — |
Derivatives designated as net investment hedges |  |  |  |  |  |  |
Cross-currency swap contracts gain/(loss): |  |  |  |  |  |  |
Recognized in Other comprehensive (loss)/income | (41) |  |  | 59 |  |  | 9 |  |  | 94
Foreign exchange contracts gain/(loss): |  |  |  |  |  |  |
Recognized in Other comprehensive (loss)/income | (75) |  |  | 18 |  |  | (34) |  |  | 18 |
Non-derivatives designated as net investment hedges |  |  |  |  |  |  |
Non-U.S. dollar borrowings gain/(loss): |  |  |  |  |  |  |
Recognized in Other comprehensive (loss)/income | — |  |  | — |  |  | — |  |  | (10) |

X
- References No definition available. + Details
Name: | us-gaap_FairValueDisclosuresAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 820 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/820/tableOfContent + Details
Name: | us-gaap_FairValueMeasurementInputsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration